Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study investigates Wegovy's safety for pregnant women

NCT ID NCT05503927

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jan 16, 2026 · Last updated May 25, 2026 · Updated 16 times

Summary

This study uses insurance records to compare health outcomes for mothers and babies when Wegovy is taken during pregnancy versus when it is not. Researchers will look at birth defects and other issues in about 1,139 women aged 15-45. The goal is to help patients and doctors make informed decisions about using Wegovy while pregnant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Novo Nordisk Investigational Site

    Princeton, New Jersey, 08540, United States

Conditions

Explore the condition pages connected to this study.